Ikan Biotech has obtained the Certificate under the standard UNE 166002 for the R&D&I management system. AENOR (Spanish Association for Standardization and Certification) certifies that Ikan Biotech has a R&D&I management system according to the UNE 166002:2014 standard for its…
Ikan Biotech will participate in strategic project "MINERVA": a genomic study for personalizing the diagnosis and treatment of patients with chronic heart failure and chronic kidney disease.
The company Ikan Biotech has been officially recognized as INNOVATIVE SME by the Spanish Government and the Ministries of Economy and Competitiveness
The Zebrafish Lab uses zebrafish, cheaper and more effective than mice, to investigate new treatments
The worrying and increasing development of bacterial resistance due to overuse has made that alternative strategies to the therapeutic use of antibiotics are sought. One of them is the application of phage-encoded lytic proteins. This is a technology that can quickly eliminate specific pathogens and prevent the emergence of multidrug resistance.